ATE385494T1 - Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents
Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittelInfo
- Publication number
- ATE385494T1 ATE385494T1 AT01986297T AT01986297T ATE385494T1 AT E385494 T1 ATE385494 T1 AT E385494T1 AT 01986297 T AT01986297 T AT 01986297T AT 01986297 T AT01986297 T AT 01986297T AT E385494 T1 ATE385494 T1 AT E385494T1
- Authority
- AT
- Austria
- Prior art keywords
- citrullimycines
- production
- medicinal product
- medicinal
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121566A EP1193249A1 (de) | 2000-10-02 | 2000-10-02 | Citrullimycine, ein Verfahren zur Herstellung derselben, und deren Verwendung als Pharmazeutika |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE385494T1 true ATE385494T1 (de) | 2008-02-15 |
Family
ID=8169998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01986297T ATE385494T1 (de) | 2000-10-02 | 2001-09-27 | Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Country Status (14)
Country | Link |
---|---|
US (1) | US6930130B2 (de) |
EP (2) | EP1193249A1 (de) |
JP (1) | JP2004510758A (de) |
AR (1) | AR032478A1 (de) |
AT (1) | ATE385494T1 (de) |
AU (2) | AU2356602A (de) |
CA (1) | CA2424273A1 (de) |
DE (1) | DE60132703T2 (de) |
DK (1) | DK1324980T3 (de) |
ES (1) | ES2298279T3 (de) |
IL (1) | IL155101A0 (de) |
MX (1) | MXPA03002343A (de) |
PT (1) | PT1324980E (de) |
WO (1) | WO2002028824A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040012396A (ko) * | 2002-08-03 | 2004-02-11 | 대한민국(관리부서:농촌진흥청) | 뇌신경성장인자 증강작용을 갖는 백강잠 추출물 및 이의활성성분을 함유하는 약학적 제제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252472A (en) * | 1988-03-22 | 1993-10-12 | Hoechst Aktiengesellschaft | Process for the production of furans and lactones from streptomyces |
-
2000
- 2000-10-02 EP EP00121566A patent/EP1193249A1/de not_active Withdrawn
-
2001
- 2001-09-27 DE DE60132703T patent/DE60132703T2/de not_active Expired - Lifetime
- 2001-09-27 JP JP2002532410A patent/JP2004510758A/ja not_active Withdrawn
- 2001-09-27 IL IL15510101A patent/IL155101A0/xx unknown
- 2001-09-27 EP EP01986297A patent/EP1324980B1/de not_active Expired - Lifetime
- 2001-09-27 PT PT01986297T patent/PT1324980E/pt unknown
- 2001-09-27 ES ES01986297T patent/ES2298279T3/es not_active Expired - Lifetime
- 2001-09-27 MX MXPA03002343A patent/MXPA03002343A/es active IP Right Grant
- 2001-09-27 AU AU2356602A patent/AU2356602A/xx active Pending
- 2001-09-27 DK DK01986297T patent/DK1324980T3/da active
- 2001-09-27 AU AU2002223566A patent/AU2002223566B2/en not_active Ceased
- 2001-09-27 CA CA002424273A patent/CA2424273A1/en not_active Abandoned
- 2001-09-27 AT AT01986297T patent/ATE385494T1/de not_active IP Right Cessation
- 2001-09-27 WO PCT/EP2001/011192 patent/WO2002028824A1/en active IP Right Grant
- 2001-09-28 AR ARP010104597A patent/AR032478A1/es unknown
- 2001-10-01 US US09/966,109 patent/US6930130B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MXPA03002343A (es) | 2003-06-30 |
PT1324980E (pt) | 2008-04-01 |
US20020065316A1 (en) | 2002-05-30 |
US6930130B2 (en) | 2005-08-16 |
EP1324980B1 (de) | 2008-02-06 |
DE60132703T2 (de) | 2009-02-05 |
AU2002223566B2 (en) | 2005-12-22 |
DK1324980T3 (da) | 2008-05-13 |
DE60132703D1 (de) | 2008-03-20 |
EP1193249A1 (de) | 2002-04-03 |
AU2356602A (en) | 2002-04-15 |
ES2298279T3 (es) | 2008-05-16 |
CA2424273A1 (en) | 2002-04-11 |
IL155101A0 (en) | 2003-10-31 |
AR032478A1 (es) | 2003-11-12 |
JP2004510758A (ja) | 2004-04-08 |
EP1324980A1 (de) | 2003-07-09 |
WO2002028824A1 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50102147D1 (de) | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE302754T1 (de) | Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE490256T1 (de) | Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE332898T1 (de) | Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
ATE528288T1 (de) | Anthranilsäureamide, verfahren zu ihrer herstellung, ihre verwendung als antiarrhythmika sowie pharmazeutische zubereitungen davon | |
DE50207011D1 (de) | Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel | |
ATE272634T1 (de) | Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung | |
DE50213372D1 (de) | Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
DE50011818D1 (de) | Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung | |
DE60103395D1 (de) | 1,4-diazabicyclo[3.2.2]nonanbenzoxazol-, benzothiazol- und benzoimidazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
ATE210638T1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
ATE304534T1 (de) | Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE59912402D1 (de) | Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE59811477D1 (de) | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE59902408D1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
DE50000560D1 (de) | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE313556T1 (de) | Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung | |
DE69709732T2 (de) | Aromatische ribose-substituierte derivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel | |
ATE263755T1 (de) | Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
ATE288442T1 (de) | Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben | |
ATE248171T1 (de) | Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen | |
DE50107787D1 (de) | Acesulfam-Metall-Komplexe, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE50011022D1 (de) | Polycyclische 2-amino-dihydrothiazolsysteme, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ATE225854T1 (de) | Vancoresmycin, verfahren zu dessen herstellung und dessen anwendung als arzneimittel | |
ATE328103T1 (de) | Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1324980 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |